Atlas Trials

A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder

Clinical trial NCT00240721 · COMPLETED

Trial details

NCT number
NCT00240721
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Bipolar DisordersMood DisordersAffective Disorders, Psychotic
Start date
2000-10-01
Enrollment
363

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.